Craft

Omnicell

Stock Price

$30.8

2023-11-10

Market Capitalization

$1.4 B

2023-11-10

Revenue

$1.3 B

FY, 2022

Omnicell Summary

Company Summary

Overview
Omnicell is a provider of pharmacy and medication management solutions for the healthcare industry. It offers hospital inventory management and drug diversion analytic dashboards, a pharmacy automation platform, point-of-care clinical workflow automation tools, patient engagement software, omnichannel communications solutions, and other products.
Type
Public
Status
Active
Founded
1992
HQ
Fort Worth, TX, US | view all locations
Website
https://www.omnicell.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Randall Lipps

    Randall Lipps, Chairman, President, Chief Executive Officer, and Founder

  • Vicki MacDevitt
  • Giri Chodavarapu

    Giri Chodavarapu, Senior Vice President, Chief Information Officer

  • Diane Kaye

    Diane Kaye, Senior Vice President, Chief Product Officer

Operating MetricsView all

Backlog

$900K
50.0%

FY, 2022

Facility Space Leased, sq. ft.

596.3K
23.8%

FY, 2022

Hospitals Served

7K

FY, 2020

LocationsView all

18 locations detected

  • Fort Worth, TX HQ

    United States

    4220 North Fwy

  • Cranberry Township, PA

    United States

    500 Cranberry Woods Dr

  • Grapevine, TX

    United States

    1620 W Northwest Hwy STE 100

  • Milpitas, CA

    United States

    725 Sycamore Dr

  • Saint Petersburg, FL

    United States

    2003 Gandy Blvd N

  • Warrendale, PA

    United States

    51 Pennwood Pl #400

and 12 others

Omnicell Financials

Summary Financials

Revenue (Q3, 2023)
$298.7M
Gross profit (Q3, 2023)
$132.0M
Net income (Q3, 2023)
$5.6M
Cash (Q3, 2023)
$446.8M
EBIT (Q3, 2023)
$3.7M
Enterprise value
$995.2M

Footer menu